How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

8,865 results for

Chemical Dependency Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Chemical Dependency Management

Chemical Dependency Management Chemical Dependency Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical Dependency (...) Management Chemical Dependency Management Aka: Chemical Dependency Management From Related Chapters II. Management See See See See See Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Chemical Dependency Management." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Chemical Dependency About FPnotebook.com is a rapid access, point-of-care

2018 FP Notebook

2. Urinary incontinence and pelvic organ prolapse in women: management

Urinary incontinence and pelvic organ prolapse in women: management Urinary incontinence and pelvic organ Urinary incontinence and pelvic organ prolapse in women: management prolapse in women: management NICE guideline Published: 2 April 2019 nice.org.uk/guidance/ng123 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view (...) failed, and the woman wishes to think about a surgical procedure, offer her the choice of: colposuspension (open or laparoscopic) or or an autologous rectus fascial sling. Also include the option of a retropubic mid-urethral mesh sling in this choice but see recommendations 1.5.7 to 1.5.11 for additional guidance on the use of mid-urethral mesh sling procedures for stress urinary incontinence. [2019] [2019] 1.5.3 Consider intramural bulking agents to manage stress urinary incontinence if alternative

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

3. Water, sanitation, hygiene and waste management for COVID-19

Water, sanitation, hygiene and waste management for COVID-19 -1- Water, sanitation, hygiene, and waste management for the COVID-19 virus Interim guidance 23 April 2020 Background This interim guidance supplements the infection prevention and control (IPC) documents by summarizing WHO guidance on water, sanitation and health-care waste relevant to viruses, including coronaviruses. It is intended for water and sanitation practitioners and providers, and health-care providers who want to know more (...) , using the right technique with either a These coronaviruses include: human coronavirus 229E (HCoV), human coronavirus HKU1, human coronavirus OC43, severe acute respiratory syndrome coronavirus alcohol-based hand rub or soap and water is critical. • Existing WHO guidance on the safe management of drinking-water and sanitation services applies to the COVID-19 outbreak. Water disinfection and sanitation treatment can reduce viruses. Sanitation workers should have proper training and access to personal

2020 WHO Coronavirus disease (COVID-19) Pandemic

4. Managing opioid use disorder in primary care: PEER simplified guideline

, the management of chronic pain in patients taking OAT remains unclear. One RCT found that all patients with chronic pain ran- domized to tapering off OAT dropped out of the study. A second RCT suggested that buprenorphine was not different from methadone for pain symptoms. 22 Beyond maintaining patients on OAT, the evidence does not pro- vide adequate guidance on the issue of chronic pain. Other examples of comorbidities that add complex- ity to the care of patients with OUD include insomnia, anxiety (...) . Methadone program. Ottawa, ON: Government of Canada; 2017. Available from: www.canada.ca/en/health-canada/services/health-concerns/controlled-substances- precursor-chemicals/exemptions/methadone-program.html. Accessed 2019 Mar 10. 18. Bruneau J, Ahamad K, Goyer MÉ, Poulin G, Selby P, Fischer B, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ 2018;190:E247-57. 19. Allan GM, Lindblad AJ, Comeau A, Coppola J, Hudson B, Mannarino M, et al. Simplified lipid guidelines

2019 CPG Infobase

5. British guideline on the management of asthma

British guideline on the management of asthma SIGN158 British guideline on the management of asthma A national clinical guideline First published 2003 Revised edition published July 2019Key to evidence statements and recommendations Levels of evidence 1 ++ High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 1 + Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias 1 – Meta-analyses, systematic reviews, or RCTs with a high risk (...) at the time of publication. However, in the event of errors or omissions corrections will be published in the web version of this document, which is the definitive version at all times. This version can be found on our web site www.sign.ac.uk NHS Evidence has accredited the process used by Scottish Intercollegiate Guidelines Network to produce clinical guidelines. Accreditation is applicable to guidance produced using the processes described in SIGN 50: a guideline developer’s handbook, 2011 edition

2019 SIGN

6. Asthma: diagnosis, monitoring and chronic asthma management

Asthma: diagnosis, monitoring and chronic asthma management Asthma: diagnosis, monitoring and Asthma: diagnosis, monitoring and chronic asthma management chronic asthma management NICE guideline Published: 29 November 2017 nice.org.uk/guidance/ng80 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived (...) on their current treatment. Where the recommendations represent a change from Asthma: diagnosis, monitoring and chronic asthma management (NG80) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 18 of 38traditional clinical practice, children and young people whose asthma is well controlled on their current treatment should not have their treatment changed purely to follow guidance. 1.7.1 Offer a SABA as reliever therapy

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

7. Skin changes suggestive of chemical dependency

Skin changes suggestive of chemical dependency Skin changes suggestive of chemical dependency Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Skin changes suggestive of chemical dependency Skin changes suggestive of chemical dependency Aka: Skin changes suggestive of chemical dependency , Dermatologic findings in chemical dependency II. Findings "Pop" Scars from s (esp. , ) Abscesses, Infections, or Ulcerations Infective or chemical reactions Dominant thumb is burned in crack abuse (lighter) Paint or oil stains ( ) Clothing Skin s Skin tracks or related scars Marks are multiple, hyperpigmented and linear New lesions may

2018 FP Notebook

8. Eye Examination Signs of Chemical Dependency

Eye Examination Signs of Chemical Dependency Eye Examination Signs of Chemical Dependency Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Eye Examination Signs of Chemical Dependency Eye Examination Signs of Chemical Dependency Aka: Eye Examination Signs of Chemical Dependency , Substance-Induced Eye Findings II. Exam: Observation Blank stare Glazing (film over ) Excessive ( ) Red ( , inhalant) Walleye or Bug-eye appearance ( ) ( ) Swelling of s ( or ) Retracted upper lid ( ) III. Exam: Pupil size and response ( ) s ( , ) (e.g. s) s ( , PCP) ( ) s (e.g. , ) s (e.g. s) Slow, delayed, sluggish or absent pupil response IV. Exam

2018 FP Notebook

9. Chemical Dependency Brief Counseling

Chemical Dependency Brief Counseling Chemical Dependency Brief Counseling Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical (...) Dependency Brief Counseling Chemical Dependency Brief Counseling Aka: Chemical Dependency Brief Counseling , Counseling Briefly for Cessation of Chemical Use , FRAMES Technique II. Indication Brief counseling by primary physician III. Protocol: Example for Alcohol use Initial physician visit for 15 minutes Use What are drinking triggers for this patient? Review risks for this patient for continued use Set specific goals for cessation or reduction Patient's personal responsibility Determine schedule

2018 FP Notebook

10. Chemical Dependency Resources

Chemical Dependency Resources Chemical Dependency Resources Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical Dependency (...) Resources Chemical Dependency Resources Aka: Chemical Dependency Resources , Substance Abuse Resources From Related Chapters II. Resources: Addiction Information SAMHSA Helpline National Institute on (NIDA) III. Resources: Addiction Treatment and Support Programs Al-Anon and Alateen ics Anonymous Anonymous s Anonymous IV. Resources: Facility and Physician Locators SAMHSA Treatment Facility Locator American Society of Addiction Medicine Treatment Links Images: Related links to external sites (from Bing

2018 FP Notebook

11. Chemical Dependency

Chemical Dependency Chemical Dependency Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical Dependency Chemical Dependency Aka (...) : Chemical Dependency , Chemical Dependence , Drug Dependence , Chemical Intoxication , Intoxication , Substance Abuse , Substance Misuse , Drug Abuse , AODA , Drugs of Abuse From Related Chapters II. Epidemiology (2015, U.S. over age 10 years old): 10% Teenagers <14 years old who use substances will have a 33% risk of substance use disorder longterm Substance use goes undiagnosed in 43% of cases in the primary care setting III. Preparations: Primary abused substances Precautions Substances of abuse

2018 FP Notebook

12. Guidelines on Supraventricular Tachycardia (for the management of patients with) Full Text available with Trip Pro

Guidelines on Supraventricular Tachycardia (for the management of patients with) 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie (...) settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European

2019 European Society of Cardiology

13. Management of Dyslipidaemias Full Text available with Trip Pro

Management of Dyslipidaemias 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk : The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) François Mach Chairperson Switzerland Corresponding authors: François Mach, Cardiology Department, Geneva University Hospital, 4 Gabrielle-Perret-Gentil, 1211 Geneva

2019 European Society of Cardiology

14. Management of Poisoning

/ Anticholinergics 118 8 Psychotropics 126 9 Organophosphates 152 10 Industrial chemicals 171 11 Caustics / detergents 179 12 Bites and stings 186 Annex A: Commonly-used antidotes Annex B: Serum toxicity ranges and toxicology laboratory services in Singapore Annex C: Socio-psychiatric aspects of poisons management Annex D: Resources for industrial chemical exposure Annex E: Alternative medicine 199 255 265 270 275 References Self-assessment (MCQs) Workgroup members Acknowledgements 281 328 334 336Foreword (...) It is estimated that 350,000 people died worldwide from unintentional poisoning in 2002. 1 In Singapore, injuries (including poisoning) ranked as the ? fth leading cause of death and the leading cause of hospitalisation from 2007 to 2009. The pattern of poisoning has changed as the public is now exposed to other new drugs and chemicals. New antidotes and therapies have also been developed for the management of such poisoning, and are now available to health professionals. The Ministry of Health released its

2020 Ministry of Health, Singapore

15. OneTouch digital system for diabetes management

OneTouch digital system for diabetes management IMTO | 1 IMTO 01-20 January 2020 Innovative Medical Technology Overview OneTouch digital system for diabetes management, remote real-time patient monitoring and remote consultations. Key points • The OneTouch digital system allows real-time sharing and monitoring of blood glucose data via a smartphone app and dedicated data cloud. • The OneTouch digital system is the first third party real-time data sharing platform to be integrated (...) of diabetes self-management. To achieve maximum benefits from self-monitoring, patients need to be able to review, understand, interpret and respond to the information obtained by self-monitoring devices. It should be noted that the general management of type 2 diabetes is focused on early intensive weight management with a goal of remission. Blood glucose meters are self-monitoring devices that aim to improve glycaemic control by measuring blood glucose levels and facilitating improved understanding

2020 SHTG Advice Statements

16. Benzene: health effects, incident management, and toxicology

Benzene: health effects, incident management, and toxicology PHE publications gateway number: 2014790 Published: October 2016 Benzene General Information Key Points • benzene is a colourless, volatile liquid with a characteristic sweet odour • it is an important chemical required for the manufacture of a wide range of materials including plastics, foams, dyes, detergents, solvents, and insecticides • major sources of benzene include vehicle exhaust, evaporation of petrol, petrol manufacturing (...) to benzene how might it affect my health? The presence of benzene in the environment does not always lead to exposure. In order for it to cause any adverse health effects you must come into contact with it. You may be exposed to benzene by breathing or ingesting the substance, or by skin or eye contact. Compendium of Chemical Hazards: Benzene Page 3 of 4 General Information Following exposure to any chemical, the adverse health effects you may encounter depend on several factors, including the amount

2019 Public Health England

17. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis Full Text available with Trip Pro

management of patients with this highly morbid condition. Methods This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology . This review is framed around the 15 best practice advice points (...) systemic inflammatory response syndrome. However, management of patients with pancreatic necrosis depends on other critical issues, such as appropriate use of imaging, intravenous fluids, antibiotics, and nutritional support, in addition to the type and timing of endoscopic, radiologic, and/or surgical interventions. Evidence-based guidelines on the management of acute pancreatitis reported that Grade 1A evidence exists to support an initial minimally invasive drainage approach to infected walled-off

2020 American Gastroenterological Association Institute

18. Management of Cancer Medication-Related Infusion Reactions

with a drug’s mechanism of action. 1,2 The incidence of IRs varies depending on the anticancer agent used. In some cases, the incidence of reactions may be low but the risk for potentially life-threatening reactions exists. 2,3 Most IRs occur within the first hour of either the first or second administration of an intravenous anticancer medication; therefore, careful monitoring during infusion initiation is necessary to detect potential IRs and manage accordingly. 3 In cases where IRs may be prevented (...) practice guideline, informed by best available evidence and expert consensus, was developed to help standardize the prevention and management of IRs across the province. Definitions The term IR is a broad classification; therefore, a standardized definition is needed to facilitate accurate documentation of reactions and provide guidance on treatment and re-challenge decision-making. An infusion reaction (IR) is any adverse sign or symptom that occurs during the infusion of a medication or within

2019 Cancer Care Ontario

19. Management of Blood Borne Viruses within the Haemodialysis Unit

Management of Blood Borne Viruses within the Haemodialysis Unit Clinical Practice Guideline Management of Blood Borne Viruses within the Haemodialysis Unit Authors: Dr Elizabeth Garthwaite – Chair Consultant Nephrologist, Leeds Teaching Hospitals NHS Trust Dr Veena Reddy Consultant Nephrologist, Sheffield Teaching Hospitals NHS Foundation Trust Dr Sam Douthwaite Consultant Virologist, Guy’s and St. Thomas’ NHS Trust, London Dr Simon Lines Consultant Nephrologist, Norwich and Norfolk University (...) Immunoglobulin Dosage 14 & 46 3. KDIGO Hepatitis C guideline summary of hygienic precautions for dialysis machines 23 - 24 4. Patients at high risk for new BBV infection 27 5. Interpretation of HBV results prior to vaccination 38 Appendix 1. Guidance on classifying risk of BBV exposure for patients dialysing away from base 50 2. Examples of questions to be included in local risk assessment on return from DAFB 51 Renal Association Clinical Practice Guideline – Blood Borne Viruses – June 2019 4 1. Introduction

2019 Renal Association

20. American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases

American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases 1 Arthritis & Rheumatology Vol. 0, No. 0, Month 2020, pp 1–28 DOI 10.1002/art.41191 © 2019, American College of Rheumatology 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases Lisa R. Sammaritano, 1 Bonnie L. Bermas, 2 Eliza E. Chakravarty, 3 Christina Chambers, 4 Megan E. B. Clowse, 5 (...) Laura L. Tarter, 17 Mehret Birru Talabi, 24 Marat Turgunbaev, 22 Amy Turner, 22 and Kristen E. D’Anci 23 Objective. To develop an evidence- based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medication use in patients with rheumatic and musculoskeletal disease (RMD). Methods. We conducted a systematic review of evidence relating

2020 American College of Rheumatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>